Author:
Reena Km.,Singh Lalit,Kumar Tiwari Ritesh
Abstract
Rheumatoid arthritis (RA) and psoriatic arthritis (PsA) are chronic inflammatory illnesses categorized by joint pain and swelling, along with systemic symptoms. The distinction between RA and PsA may be difficult to determine since their clinical presentations and symptoms are so similar. RA and PsA are treated in a palliative manner since they are not curable diseases. Allopathic medicines have serious side effects, and long term-consumption decreases patient quality of life. Hyperacidity, edema, stomach ulcers, gastrointestinal bleeding, perforation, and reduced appetite are some of the most common adverse effects. Curcumin, the primary active component within Curcuma longa (turmeric), has been demonstrated to be helpful in treating RA and PsA, with effectiveness attributed to its mode of activity. This chapter defines the correlation between RA and PsA and reports on the use and mechanism of curcumin in the management of these conditions. According to various literature surveys and evidence, it can be concluded that curcumin is a safe and effective therapeutic option for managing RA and PsA compared to synthetic medications.